Clinical Trial Update: An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States [Phase 2]

View source ↗

Summary

An extension study of entacapone for Parkinson's disease completed; not recruiting in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Entacapone (Entacapone)

Snippet

Sponsor: Novartis | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED